Susan Horvath
2019
In 2019, Susan Horvath earned a total compensation of $401.4K as Chief Financial Officer and Vice President of Finance at Panbela Therapeutics.
Compensation breakdown
| Option Awards | $181,124 |
|---|---|
| Salary | $220,313 |
| Total | $401,436 |
Horvath received $220.3K in salary, accounting for 55% of the total pay in 2019.
Horvath also received $181.1K in option awards.
Rankings
In 2019, Susan Horvath's compensation ranked 12,331st out of 13,971 executives tracked by ExecPay. In other words, Horvath earned more than 11.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,331 out of 13,971 | 12th |
Division Manufacturing | 4,990 out of 5,695 | 12th |
Major group Chemicals And Allied Products | 1,962 out of 2,194 | 11th |
Industry group Drugs | 1,688 out of 1,880 | 10th |
Industry Pharmaceutical Preparations | 1,249 out of 1,392 | 10th |
Source: SEC filing on April 15, 2021.
Horvath's colleagues
We found one more compensation record of an executive who worked with Susan Horvath at Panbela Therapeutics in 2019.
2019
Michael Cullen
Panbela Therapeutics